Myelin Repair Provides Novel Multiple Sclerosis Treatment

Click here to view original web page at Myelin Repair Provides Novel Multiple Sclerosis Treatment

Summary: Researchers discovered a promising treatment for multiple sclerosis (MS) using a novel protein function inhibitor, ESI1, which effectively regenerates myelin—a crucial protective coating on nerve cells that deteriorates in MS. The study showcases that ESI1 reactivates the brain’s capacity to produce myelin, overcoming traditional barriers that have hindered […]

Blood Test Predicts Multiple Sclerosis Years Before Symptoms Appear

Click here to view original web page at Blood Test Predicts Multiple Sclerosis Years Before Symptoms Appear

Summary: Researchers identified a specific pattern of autoantibodies in the blood that precedes the clinical onset of multiple sclerosis (MS), potentially paving the way for early diagnosis and treatment. Their study found that 10% of MS patients displayed a unique set of autoantibodies against both human proteins and common […]

Household Chemicals Linked to Brain Health Risks

Click here to view original web page at Household Chemicals Linked to Brain Health Risks

Summary: Certain household chemicals, including those found in personal-care products and furniture, pose a risk to brain health, potentially contributing to diseases like multiple sclerosis and autism. The study reveals that these chemicals damage oligodendrocytes, essential cells for nerve cell protection. Key findings include the identification of harmful organophosphate […]

First Human Trials Test Light and Sound Therapy For Alzheimer’s Disease 23

Click here to view original web page at First Human Trials Test Light and Sound Therapy For Alzheimer’s Disease 23

A new study published in the journal PLoS ONE has reported on the first human tests of an experimental therapy using sound and light to treat Alzheimer’s disease (AD). New Atlas reports: Over the last seven years, Li-Huei Tsai and colleagues at MIT’s Picower Institute for Learning and Memory […]

Potential New Treatment for “Brain Fog” in Long COVID Patients

Click here to view original web page at Potential New Treatment for “Brain Fog” in Long COVID Patients

Summary: Researchers identified two FDA-approved drugs that can mitigate or even eliminate the brain fog associated with COVID-19 infection. Source: Yale Individuals with long COVID, sometimes referred to as “long-haulers,” experience symptoms that may persist for weeks, months, or even years after their acute viral infection. While symptoms vary […]

Potential New Treatment for “Brain Fog” in Long COVID Patients

Click here to view original web page at Potential New Treatment for “Brain Fog” in Long COVID Patients

Summary: Researchers identified two FDA-approved drugs that can mitigate or even eliminate the brain fog associated with COVID-19 infection. Source: Yale Individuals with long COVID, sometimes referred to as “long-haulers,” experience symptoms that may persist for weeks, months, or even years after their acute viral infection. While symptoms vary […]

Light therapy could be a promising non-drug treatment option for multiple sclerosis-related fatigue

Click here to view original web page at Light therapy could be a promising non-drug treatment option for multiple sclerosis-related fatigue

Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is described by the vast majority of patients as the most distressing symptom. In a recent scientific study, a research group led by Stefan Seidel from the Department of Neurology at MedUni Vienna and AKH Vienna […]

The Top 10 Neuroscience Stories of 2022

Click here to view original web page at The Top 10 Neuroscience Stories of 2022

From discoveries about the origins of multiple sclerosis to a potential new drug for Alzheimer’s disease – it has been a busy 2022 for the brain. After another huge year in neuroscience, we review 10 of the most important developments in the field. 1. Multiple Sclerosis Is Likely Caused […]

A Connection Between Diabetes Medications and Multiple Sclerosis

Click here to view original web page at A Connection Between Diabetes Medications and Multiple Sclerosis

Summary: People over the age of 45 who use anti-hyperglycemic medications to control their Type 2 diabetes are at increased risk of developing multiple sclerosis. However, those who are under 45 and take anti-hyperglycemic medications are at reduced risk of MS. Source: University of Arizona A new University of […]

A Connection Between Diabetes Medications and Multiple Sclerosis

Click here to view original web page at A Connection Between Diabetes Medications and Multiple Sclerosis

Summary: People over the age of 45 who use anti-hyperglycemic medications to control their Type 2 diabetes are at increased risk of developing multiple sclerosis. However, those who are under 45 and take anti-hyperglycemic medications are at reduced risk of MS. Source: University of Arizona A new University of […]